Treatments

These posts deal with some the possible treatments for prostate cancer.

Home » Treatments

Gleason 6 Is Bogus Prostate Cancer

Noted urologic surgeon Bert Vorstman, MD, MS, FAAP, FRACS, FACS today has issued a stinging report regarding the unreliable PSA test, the mislabeling of the common Gleason 6 prostate disease as a cancer, and the misrepresentation that the radical (robotic) prostatectomy treatment is scientifically proven to be safe and effective – a charade that represents an outrageous and shameful trifecta of abominations. Read the article.

Gleason 6 Is Bogus Prostate Cancer Read More »

Age-related risks of radical prostatectomy

It will hardly come as a surprise to most prostate cancer support group leaders and other prostate cancer advocates that there is a strong association between patient age and risk for side effects of radical prostatectomy. However, we now have a rather more sophisticated set of insight into such risks. Read the article.

Age-related risks of radical prostatectomy Read More »

Active Surveillance for Intermediate Risk Prostate Cancer: Survival Outcomes in the Sunnybrook Experience.

Data from the survival outcomes of patients support the use of active surveillance in low risk and intermediate risk cases of Gleason 6 but not Gleason 7 prostate cancer. Multiparametric magnetic resonance imaging and novel biomarkers might be vital in detecting favorable Gleason 7 disease. Read the article here.

Active Surveillance for Intermediate Risk Prostate Cancer: Survival Outcomes in the Sunnybrook Experience. Read More »

Magnetic resonance spectroscopy-based method may help predict prostate cancer aggressiveness

Metabolic analysis of benign tissue samples from men with prostate cancer allowed researchers to retrospectively predict the aggressiveness of disease and likelihood of recurrence, according to study results. Read the article here.

Magnetic resonance spectroscopy-based method may help predict prostate cancer aggressiveness Read More »

Canadian lab takes a shot at producing cancer-killing treatment dubbed the ‘rarest drug on Earth’

Canada’s particle physics laboratory TRIUMF is making a push to be a future world leader in the production of a special radioactive isotope nicknamed the “rarest drug on Earth,” which can deliver devastating amounts of energy to single cancer cells, without harming nearby tissue. Read the article here.

Canadian lab takes a shot at producing cancer-killing treatment dubbed the ‘rarest drug on Earth’ Read More »

Scroll to Top